{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:06:09Z","timestamp":1781579169946,"version":"3.54.5"},"reference-count":5,"publisher":"Galenos Yayinevi","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjo"],"DOI":"10.4274\/tjo.galenos.2025.36524","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T11:00:00Z","timestamp":1766660400000},"page":"350-351","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological Pinhole in Presbyopia Treatment: A Brief History from Pilocarpine to Aceclidine"],"prefix":"10.4274","volume":"55","author":[{"given":"Pelin","family":"\u00d6zyol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"ref0","unstructured":"1. Lenz Therapeutics, VIZZ\u2122'in presbiyopi tedavisi i\u00e7in ABD FDA onay\u0131, 31 July 2025, https:\/\/ir.lenz-tx.com\/news-events\/press-releases\/detail\/39\/lenz-therapeutics-announces-us-fda-approval-of-vizz-for-the-treatment-of-presbyopia"},{"key":"ref1","unstructured":"2. ClinicalTrials.gov. A dose-ranging study to evaluate the safety and efficacy of UNR844 in subjects with presbyopia (READER). ClinicalTrials.gov identifier NCT04806503. Last updated 2024-06-20 Accessed August 17, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04806503"},{"key":"ref2","unstructured":"3. Bartlett D, Jaanus SD (eds). Clinical ocular pharmacology. 5th ed. St. Louis: Elsevier; 2008."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/jop.1998.14.363","article-title":"Selectivity of muscarinic agonists including (+\/-)-aceclidine and antimuscarinics on the human intraocular muscles","volume":"14","author":"Ishikawa","year":"1998","unstructured":"4. Ishikawa H, DeSantis L, Patil PN. Selectivity of muscarinic agonists including (+\/-)-aceclidine and antimuscarinics on the human intraocular muscles. J Ocul Pharmacol Ther. 1998;14:363-373.","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref4","unstructured":"5. Vuity - pilocarpine ophthalmic solution for presbyopia. Med Lett Drugs Ther. 2022;64:17-18. http:\/\/secure.medicalletter.org\/TML-article-1643a"}],"container-title":["Turkish Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T06:45:57Z","timestamp":1766731557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oftalmoloji.org\/articles\/pharmacological-pinhole-in-presbyopia-treatment-a-brief-history-from-pilocarpine-to-aceclidine\/doi\/tjo.galenos.2025.36524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":5,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,25]]}},"URL":"https:\/\/doi.org\/10.4274\/tjo.galenos.2025.36524","relation":{},"ISSN":["1300-0659","2147-2661"],"issn-type":[{"value":"1300-0659","type":"print"},{"value":"2147-2661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}